» Articles » PMID: 24122041

DGIdb: Mining the Druggable Genome

Abstract

The Drug-Gene Interaction database (DGIdb) mines existing resources that generate hypotheses about how mutated genes might be targeted therapeutically or prioritized for drug development. It provides an interface for searching lists of genes against a compendium of drug-gene interactions and potentially 'druggable' genes. DGIdb can be accessed at http://dgidb.org/.

Citing Articles

Genomics-Informed Drug Repurposing Strategy Identifies Novel Therapeutic Targets for Metabolic Dysfunction-Associated Steatotic Liver Disease.

Seagle H, Akerele A, DeCorte J, Hellwege J, Breeyear J, Kim J medRxiv. 2025; .

PMID: 40034783 PMC: 11875238. DOI: 10.1101/2025.02.18.25321035.


Personalized prediction of anticancer potential of non-oncology drugs through learning from genome derived molecular pathways.

Dong X, Liu H, Tong T, Wu L, Wang J, You T NPJ Precis Oncol. 2025; 9(1):36.

PMID: 39905223 PMC: 11794852. DOI: 10.1038/s41698-025-00813-z.


Exploring genetic associations and drug targets for mitochondrial proteins and schizophrenia risk.

Sun W, Sun P, Li J, Yang Q, Tian Q, Yuan S Schizophrenia (Heidelb). 2025; 11(1):10.

PMID: 39863625 PMC: 11762283. DOI: 10.1038/s41537-025-00559-4.


Systematic dissection of pleiotropic loci and critical regulons in excitatory neurons and microglia relevant to neuropsychiatric and ocular diseases.

Ma Y, Jiang D, Li J, Zheng G, Deng Y, Gou X Transl Psychiatry. 2025; 15(1):24.

PMID: 39856056 PMC: 11760387. DOI: 10.1038/s41398-025-03243-4.


Tryptophan metabolism-related gene CYP1B1 serves as a shared biomarker for both Parkinson's disease and insomnia.

Li X, Yu W, Wu J, He W, Cheng Y, Gao K Sci Rep. 2025; 15(1):1362.

PMID: 39779759 PMC: 11711247. DOI: 10.1038/s41598-024-84362-8.


References
1.
Bose R, Kavuri S, Searleman A, Shen W, Shen D, Koboldt D . Activating HER2 mutations in HER2 gene amplification negative breast cancer. Cancer Discov. 2012; 3(2):224-37. PMC: 3570596. DOI: 10.1158/2159-8290.CD-12-0349. View

2.
Kan Z, Jaiswal B, Stinson J, Janakiraman V, Bhatt D, Stern H . Diverse somatic mutation patterns and pathway alterations in human cancers. Nature. 2010; 466(7308):869-73. DOI: 10.1038/nature09208. View

3.
Banerji S, Cibulskis K, Rangel-Escareno C, Brown K, Carter S, Frederick A . Sequence analysis of mutations and translocations across breast cancer subtypes. Nature. 2012; 486(7403):405-9. PMC: 4148686. DOI: 10.1038/nature11154. View

4.
Lim E, Pon A, Djoumbou Y, Knox C, Shrivastava S, Guo A . T3DB: a comprehensively annotated database of common toxins and their targets. Nucleic Acids Res. 2009; 38(Database issue):D781-6. PMC: 2808899. DOI: 10.1093/nar/gkp934. View

5.
Russ A, Lampel S . The druggable genome: an update. Drug Discov Today. 2005; 10(23-24):1607-10. DOI: 10.1016/S1359-6446(05)03666-4. View